"10.1371_journal.pbio.0040031","plos biology","2005-12-27T00:00:00Z","Laura Bordone; Maria Carla Motta; Frederic Picard; Ashley Robinson; Ulupi S Jhala; Javier Apfeld; Thomas McDonagh; Madeleine Lemieux; Michael McBurney; Akos Szilvasi; Erin J Easlon; Su-Ju Lin; Leonard Guarente","Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; Laval Hospital Research Center, Québec City, Québec, Canada; The Whittier Institute for Diabetes, University of California San Diego, La Jolla, California, United States of America; Elixir Pharmaceuticals, Cambridge, Massachusetts, United States of America; Department of Medicine and Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, and the Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America; Center for Genetics and Development, and Section of Microbiology, University of California Davis, Davis, California, United States of America","LB and LG conceived and designed the experiments. LB, MCM, FP, USJ, AS, and EJE performed the experiments. LB, USJ, and LG analyzed the data. LB, JA, TM, ML, MM, and SJL contributed reagents/materials/analysis tools. LB and LG wrote the paper.","LG is a founder, consultant, and board member for Elixir Pharmaceuticals.","2005","12","Laura Bordone","LB",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
